This is the first industry-academia collaboration in the country, initiated through the CSR route, for advancing research in the areas of immuno-therapeutics and regenerative medicines
New AI capabilities will help scientists identify, optimize, and validate new molecules. Additional applications include manufacturing, medical imaging, and enterprise AI agents
Partnership combines MilliporeSigma’s chemistry and organoid expertise with Promega’s assay technologies
Approval broadens indication for Tezspire to a second disease characterized by epithelial-driven inflammation
Novelix will provide financial and infrastructural support for the entire technology transfer and scale-up program
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
IND clearance enables initiation of Phase 1c clinical trial in HFpEF patients with elevated endotrophin levels
Anti-microtubule binding region-tau antibody being investigated as a potential disease-modifying therapy to slow or delay progression of disease
The platform integrates artificial intelligence into a unified environment that supports optical, microCT, ultrasound, and other imaging modalities
Subscribe To Our Newsletter & Stay Updated
